Policy

Prescribing & Medicines Management Policy

Safe, lawful prescribing, sourcing, storage, administration and disposal of medicines in aesthetic practice

For Aesthetic ClinicRef BS-AES-POL-009See a sample (PDF) →
£54.99
One-off purchase · no VAT · instant download
  • Instant download after checkout
  • Editable Microsoft Word (.docx)
  • Mapped to the CQC standards
  • Optional 3-monthly updates

What's inside

This policy is fully drafted and structured, ready to brand and complete for your service. It covers:

  • 1. Purpose
  • 2. Scope
  • 3. Policy Statement and Principles
  • 4. Definitions
  • 5. Legal Status of Aesthetic Medicines
  • 6. Who May Prescribe
  • 7. Face-to-Face Assessment Before Prescribing - the Firm UK Position
  • 8. Continuing Accountability of the Prescriber
  • 9. Sourcing Medicines and Recognising Falsified Products
  • 10. Patient-Specific Treatment - No PGDs for Botulinum Toxin
  • 11. Safe Storage, Cold Chain and Stock Control
  • 12. Labelling, Reconstitution and Preparation
  • 13. Emergency Medicines and Managing Anaphylaxis and Vascular Occlusion
  • 14. Administration and the Contemporaneous Patient Record
  • 15. Reporting to the MHRA - the Yellow Card Scheme
  • 16. Safe Disposal of Medicines and Sharps
  • 17. Roles and Responsibilities
  • 18. Training and Awareness
  • 19. Monitoring, Audit and Compliance
  • 20. Related Policies
  • 21. Review and Version Control
  • 22. Disclaimer

Legislation & standards it maps to

  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Regulation 12 (Safe care and treatment)
  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Regulation 17 (Good governance)
  • Human Medicines Regulations 2012 (as amended), including Regulation 214 (restrictions on prescribing, sale and supply of prescription-only medicines)
  • Medicines Act 1968
  • Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 2001 (where any controlled drug is held)
  • Control of Substances Hazardous to Health Regulations 2002 (COSHH)
  • Environmental Protection Act 1990 and the Hazardous Waste (England and Wales) Regulations 2005 (clinical and medicines waste)
  • Health and Safety (Sharps Instruments in Healthcare) Regulations 2013

Who it applies to

All registered managers, independent prescribers, practitioners (medical, nursing, dental and non-medical injectors), clinical support staff, locums, students and contractors of [Organisation Name] who prescribe, source, store, prepare, administer, supply or dispose of medicines, or who keep the records associated with them.

Glossary

Plain-English explanations of the technical terms and legislation used in this document.

Adrenaline (epinephrine)
An emergency medicine given to reverse a severe allergic reaction (anaphylaxis).
Adverse drug reaction
An unwanted or harmful response to a medicine that was given correctly.
Adverse event
Any unexpected or unwanted occurrence linked to a treatment that harms, or could harm, a patient.
Anaphylaxis
A severe, life-threatening allergic reaction needing immediate emergency treatment.
Biostimulatory injectable
An injectable product that prompts the skin to make more of its own collagen over time, rather than simply filling a space.
Botulinum toxin type A
A prescription-only medicine injected to relax muscles and soften lines; sold under various brand names.
Care Quality Commission (CQC)
The independent regulator of health and social care services in England.
Cold chain
Keeping vaccines and certain medicines within a safe temperature range from delivery to use.
Contemporaneous record
A note written at the time of, or immediately after, the event it describes, so it is accurate and reliable.
Contraindication
A reason why a particular treatment should not be given to a particular person.
Control of Substances Hazardous to Health Regulations 2002 (COSHH)
The law for safely managing chemicals and other hazardous substances at work.
Controlled drug
A medicine whose supply, storage and records are tightly restricted by law because of its potential for misuse.
Dermal filler
An injectable gel, often based on hyaluronic acid, used to add volume or smooth the skin; usually regulated as a medical device.
Disclosure and Barring Service (DBS) check
A criminal-records check showing whether a person is suitable to work with patients or vulnerable people.
Duty of candour
The legal duty to be open and honest with a person and their family when something goes wrong with their care.
Environmental Protection Act 1990
The law setting out duties for the safe handling and disposal of waste, including clinical and hazardous waste.
Face-to-face consultation
A meeting where the prescriber is physically present with the patient to examine and assess them before prescribing.
Falsified medicine
A fake or counterfeit medicine that misrepresents what it is, where it came from or its history, and may be unsafe.
First-expiry-first-out
A stock rule of using the items with the earliest expiry date first, so nothing is wasted.
Fundamental standards
The minimum standards of safety and quality below which care must never fall.
General Dental Council (GDC)
The body that registers and regulates dentists and dental professionals in the UK.
General Medical Council (GMC)
The body that registers and regulates doctors in the UK.
General Pharmaceutical Council (GPhC)
The body that registers and regulates pharmacists and pharmacies in Great Britain.
Hazardous Waste (England and Wales) Regulations 2005
The law controlling how hazardous waste, including some medicines waste, must be stored, moved and disposed of.
Health and Safety (Sharps Instruments in Healthcare) Regulations 2013
The law requiring safe handling and disposal of needles and other sharp instruments in healthcare.
Health and Social Care Act 2008 (Regulated Activities) Regulations 2014
The regulations setting out the fundamental standards that providers of regulated care must meet.
Human Medicines Regulations 2012
The main law governing how medicines for human use are licensed, sold, supplied and prescribed in the UK.
Hyaluronic acid
A naturally occurring substance used in many dermal fillers; it can be dissolved with the medicine hyaluronidase.
Hyaluronidase
A prescription-only medicine that dissolves hyaluronic-acid filler, used in emergencies such as a blocked blood vessel.
Indemnity
Insurance or equivalent cover that pays compensation to a patient if a practitioner's care causes harm.
Independent prescriber
A qualified professional legally allowed to assess a patient and decide what medicine to prescribe.
Infection prevention and control (IPC)
The measures used to stop infection spreading between patients, staff and visitors.
Informed consent
Agreement to treatment given freely after the risks, benefits and alternatives have been clearly explained.
Intense pulsed light (IPL)
A skin treatment that uses broad-spectrum light, often for pigmentation, redness or hair removal.
Licensed indication
A use of a medicine that has been officially approved by the medicines regulator.
Local anaesthetic
A medicine that numbs a small area of the body so a procedure can be carried out without pain.
Medical device
A product such as a dermal filler used for a medical purpose that works mainly by physical means rather than as a medicine.
Medicines Act 1968
An earlier UK law on the control of medicines, parts of which still apply alongside the Human Medicines Regulations 2012.
Medicines and Healthcare products Regulatory Agency (MHRA)
The UK body that regulates medicines and medical devices and runs the Yellow Card reporting scheme.
Misuse of Drugs Act 1971
The law that classifies controlled drugs and restricts their possession and supply.
Misuse of Drugs Regulations 2001
The regulations setting out how controlled drugs may lawfully be stored, recorded, supplied and destroyed.
Near miss
An event that could have caused harm but did not, by chance or because it was caught in time.
Nursing and Midwifery Council (NMC)
The body that registers and regulates nurses and midwives in the UK.
Patient Group Direction (PGD)
A written instruction letting named staff supply or give a medicine to a group of patients without an individual prescription; it cannot be used for cosmetic botulinum toxin.
Patient-specific direction (PSD)
A written instruction from a prescriber to give a medicine to one named patient who has already been assessed.
Personal protective equipment (PPE)
Items such as gloves, aprons and masks worn to protect against harm or infection.
Prescription-only medicine (POM)
A medicine that may lawfully be supplied only on the instruction of an appropriate prescriber.
Reconstitution
Mixing a powdered medicine with the correct liquid to prepare it for use, exactly as the product instructions require.
Registered Manager
The person registered with the regulator as responsible for the day-to-day running of a service.
Regulated activity
A type of care or treatment the law requires a provider to register with the regulator to deliver.
Resuscitation Council UK
The organisation that sets the UK's recognised guidance on resuscitation and the emergency treatment of conditions such as anaphylaxis.
Risk assessment
A structured check identifying what could cause harm and what is being done to prevent it.
Sharps
Needles, blades and other items that can cut or puncture the skin.
Summary of Product Characteristics (SmPC)
The manufacturer's official document setting out how a licensed medicine should be used, dosed, stored and handled.
Vascular occlusion
A serious complication where filler blocks or presses on a blood vessel, risking tissue death or, rarely, blindness.
Whistleblowing (speaking up)
Raising a concern about wrongdoing, risk or malpractice at work, protected by law.
Wholesale Dealer's Licence (Authorisation)
An official authorisation allowing a company to lawfully buy and sell medicines in bulk to clinics and pharmacies.
Yellow Card scheme
The Medicines and Healthcare products Regulatory Agency system for reporting suspected problems with medicines and medical devices.

How it works

  1. Buy securely with Stripe - instant, no VAT, no account needed.
  2. Download your editable Word file from the link we email you straight away.
  3. Complete the placeholders for your service, then have it approved before use.
  4. Add the optional updates subscription and we keep it current as guidance changes.

Related documents

PolicyAdverse Event Management Policy£54.99
PolicySafeguarding Policy£54.99
PolicyComplaints Policy£54.99
PolicyConsent & Risk Disclosure Policy£54.99

Need the whole set?

Buy the full Aesthetic Clinic pack and save versus buying documents individually.

View the Aesthetic Clinic pack